JPRN-UMIN000004210已完成未知
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C patients with vitaminD plus peginterferon alpha-2a /ribavirin.versus alfacalcidol plus peginterferon alpha-2a /ribavirin. - Vitamin D or Alfacalcidol with peginterferon alfa-2a plus ribavirin for treatment of chronic hepatitis C patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients were excluded 1)Women of childbearing potential and pregnancy, lactating woman 2) allergic to ribavirin or nucleoside analogues 3)an uncontrollable heart trouble (myocardial infarction, heart failure, or arrhythmia) 4)hemoglobinopathy(thalassemia, sickle cell disease) 5) severe renal disease, Ccr <50ml/min 6) severe depression or psychosomatic disorders 7)severe liver disease 8) autoimmune hepatitis or HBV 9) drug allergy against interferon 10) Allergic to vaccine or biological preparations 11) Concomitant herbal medication of Sho-saikoto 12) history of interstitial pneumonia 13)Other conditions considered inappropriate by attending physician
研究者
相似试验
已完成
不适用
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C and compensated cirrhosis patients with the prescribing pattern of vitaminD plus peginterferon alpha-2a /ribavirin.Chronic hepatitisC patients and compensated cirrhosis patientsJPRN-UMIN000008342Saitama Medical University80
尚未招募
Unknown
A trial to assess the role of serial physical examination for well appearing babies at risk of sepsisCTRI/2024/04/066566ONE
招募中
2 期
Effect of cholestyramine on post-ESD ulcer healingJPRN-jRCTs031200235Tamura Shigeki100
尚未招募
2 期
To study the effect of Bhunimbadi Vati and its add-on effect with Tablet Glimepiride Metformin in Madhumeha wsr to Type 2 Diabetes mellitusCTRI/2023/03/050496Dr Kiran Damoo Ubhe
招募中
2 期
Management of pelvic organ prolapse through AyurvedaCTRI/2023/09/057495Dr Salini P